{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:35:55Z","timestamp":1791297355393,"version":"4.1.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Patients with psoriatic arthritis (PsA) are suffering from a decreased quality of life despite currently available treatments. In the latest years, novel therapies targeting the IL-17\/IL-23 and TNF pathways improved clinical outcome. Despite this, remission of disease is not achieved in a considerable group of patients, continuous treatment is very often required to reach clinical remission, and prevention of PsA in patients with psoriasis (PsO) is currently impossible. A better understanding of PsA pathogenesis is required to develop novel treatment strategies that target inflammation and destruction more effectively and at an early stage of the disease, or even before clinically manifest disease. The skin is considered as one of the sites of onset of immune activation, triggering the inflammatory cascade in PsA. PsO develops into PsA in 30% of the PsO patients. Influenced by environmental and genetic factors, the inflammatory process in the skin, entheses, and\/or gut may evolve into synovial tissue inflammation, characterized by influx of immune cells. The exact role of the innate and adaptive immune cells in disease pathogenesis is not completely known. The involvement of activated IL-17A+ T cells could implicate early immunomodulatory events generated in lymphoid organs thereby shaping the pathogenic inflammatory response leading to disease. In this perspective article, we provide the reader with an overview of the current literature regarding the immunological changes observed during the earliest stages of PsA. Moreover, we will postulate future areas of translational research aimed at increasing our knowledge on the molecular mechanisms driving disease development, which will aid the identification of novel potential therapeutic targets to limit the progression of PsA.<\/jats:p>","DOI":"10.3389\/fmed.2021.711823","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T09:01:43Z","timestamp":1629190903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints"],"prefix":"10.3389","volume":"8","author":[{"given":"Janne W.","family":"Bolt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaja M. J.","family":"van Ansenwoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Hammoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen G.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G. M.","family":"van Baarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Care Res."},{"key":"B3","first-page":"162","article-title":"The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran","volume":"11","author":"Jamshidi","year":"2008","journal-title":"Arch Iran Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","article-title":"Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis","volume":"160","author":"Reich","year":"2009","journal-title":"Br J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jaad.2014.05.010","article-title":"Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European\/North American dermatology clinics","volume":"71","author":"Mease","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B6","first-page":"2577","article-title":"Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire","volume":"29","author":"Alenius","year":"2002","journal-title":"J Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3899\/jrheum.141598","article-title":"Prevalence and clinical characteristics of psoriatic arthritis in Japan","volume":"42","author":"Ohara","year":"2015","journal-title":"J Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","article-title":"The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics","volume":"24","author":"Christophers","year":"2010","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/ard.2008.089441","article-title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: the toronto psoriatic arthritis screen (ToPAS)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/rheumatology\/kes187","article-title":"The early psoriatic arthritis screening questionnaire: A simple and fast method for the identification of arthritis in patients with psoriasis","volume":"51","author":"Tinazzi","year":"2012","journal-title":"Rheumatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000343290","article-title":"A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin","volume":"225","author":"De Groot","year":"2013","journal-title":"Dermatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","article-title":"Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis","volume":"73","author":"Villani","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1111\/jdv.13210","article-title":"Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice","volume":"29","author":"Spelman","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/jdv.15443","article-title":"Utilization of the validated psoriasis epidemiology screening tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry","volume":"33","author":"Mease","year":"2019","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","article-title":"Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey","volume":"3","author":"Kavanaugh","year":"2016","journal-title":"Rheumatol Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/annrheumdis-2018-214746","article-title":"Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate","volume":"78","author":"Van Mens","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/annrheumdis-2012-202608","article-title":"Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis","volume":"72","author":"Tillett","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/rheumatology\/keaa030","article-title":"Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis","volume":"59","author":"Hag\u00e8ge","year":"2020","journal-title":"Rheumatology."},{"key":"B21","first-page":"469","article-title":"Evaluation of an existing toool for psoriatic arthritis: the psorasis epidemiology screening tool (PEST) questionnaire","volume":"27","author":"Ibrahim","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/bjd.13272","article-title":"Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis","volume":"171","author":"Langenbruch","year":"2014","journal-title":"Br J Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2340\/00015555-2912","article-title":"Duration of psoriatic skin disease as risk factor for subsequent onset of psoriatic arthritis","volume":"98","author":"Egeberg","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/rheumatology\/ket363","article-title":"Age at disease onset: a key factor for understanding psoriatic disease","volume":"53","author":"Queiro","year":"2014","journal-title":"Rheumatology."},{"key":"B26","first-page":"476","article-title":"Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset","volume":"30","author":"Queiro","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10067-014-2630-2","article-title":"Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage","volume":"34","author":"El Miedany","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41584-021-00578-2","article-title":"Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study","volume":"17","author":"Perez-Chada","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/art.40447","article-title":"Augmented Th17 differentiation leads to cutaneous and synovio-entheseal inflammation in a novel model of psoriatic arthritis","volume":"70","author":"Yang","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1301360","article-title":"T Cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia","volume":"191","author":"Fogli","year":"2013","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/jid.2014.426","article-title":"Psoriatic inflammation facilitates the onset of arthritis in a mouse model","volume":"135","author":"Yamamoto","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/sciadv.aas9864","article-title":"Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes","volume":"4","author":"Zhong","year":"2018","journal-title":"Sci Adv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41598-020-65269-6","article-title":"Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"'MHC-I-opathy'-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11926-020-0886-x","article-title":"Complexities in genetics of psoriatic arthritis","volume":"22","author":"Rahmati","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13075-021-02545-4","article-title":"Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review","volume":"23","author":"Mulder","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/BOR.0000000000000720","article-title":"MHC class i associations beyond HLA-B27: The peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesis","volume":"32","author":"Winchester","year":"2020","journal-title":"Curr Opin Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"101691","DOI":"10.1016\/j.berh.2021.101691","article-title":"Clinical and molecular significance of genetic loci associated with psoriatic arthritis","volume":"35","author":"O'Rielly","year":"2021","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard.2010.147421","article-title":"IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients","volume":"70","author":"Eder","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/ard.2010.143123","article-title":"Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.berh.2020.101494","article-title":"The gut microbiome in psoriasis and psoriatic arthritis","volume":"33","author":"Myers","year":"2019","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bjd.17745","article-title":"Evaluation of subclinical gut inflammation using faecal calprotectin levels and colonic mucosal biopsy in patients with psoriasis and psoriatic arthritis","volume":"181","author":"Adarsh","year":"2019","journal-title":"Br J Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/art.22758","article-title":"The concept of a \u201csynovio-entheseal complex\u201d and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond","volume":"56","author":"McGonagle","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/DAD.0000000000001947","article-title":"Focal synovial inflammation versus enthesitis theory in distal psoriatic arthritis","author":"Perrin","year":"2021","journal-title":"Am J Dermatopathol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/ard.61.6.534","article-title":"Histological assessment of the early enthesitis lesion in spondyloarthropathy","volume":"61","author":"McGonagle","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/cells10020341","article-title":"IL-17A and TNF modulate normal human spinal entheseal bone and soft tissue mesenchymal stem cell osteogenesis, adipogenesis, and stromal function","volume":"10","author":"Russell","year":"2021","journal-title":"Cells."},{"key":"B52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","article-title":"Identification of myeloid cells in the human enthesis as the main source of local IL-23 production","volume":"78","author":"Bridgewood","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B53","first-page":"0","author":"Leijten","year":"","journal-title":"Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1559-0275-12-1","article-title":"Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers","volume":"12","author":"Cretu","year":"2015","journal-title":"Clin Proteom."},{"key":"B55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.clindermatol.2019.01.011","article-title":"Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: a review","volume":"37","author":"Lewis","year":"2019","journal-title":"Clin Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1046\/j.1365-2133.2003.05552.x","article-title":"Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study","volume":"149","author":"Gudjonsson","year":"2003","journal-title":"Br J Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.rdc.2015.07.006","article-title":"Etiology and pathogenesis of psoriatic arthritis","volume":"41","author":"Barnas","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"B58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/03009742.2015.1091497","article-title":"Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity","volume":"45","author":"Bierkarre","year":"2016","journal-title":"Scand J Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature."},{"key":"B62","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity."},{"key":"B63","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/annrheumdis-2020-218186","article-title":"IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors","volume":"80","author":"Nerviani","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"108513","DOI":"10.1016\/j.clim.2020.108513","article-title":"Psoriatic arthritis under the influence of IFN\u03b3","volume":"218","author":"Dai","year":"2020","journal-title":"Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, proinflammatory, tissue-resident memory phenotype and function of synovial interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","article-title":"Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis","volume":"60","author":"Tassiulas","year":"1999","journal-title":"Hum Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/path.1224","article-title":"Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes","volume":"198","author":"Paulsen","year":"2002","journal-title":"J Pathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8741","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","author":"Penkava","year":"2020","journal-title":"Nat Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1038\/s41598-019-47310-5","article-title":"Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis","volume":"9","author":"Diani","year":"2019","journal-title":"Sci Rep."},{"key":"B73","first-page":"374","article-title":"Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?","volume":"34","author":"Candia","year":"2007","journal-title":"J Rheumatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/ijms19020530","article-title":"Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints","volume":"19","author":"Boutet","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3899\/jrheum.141577","article-title":"Differential antigen-presenting B cell phenotypes from synovial microenvironment of patients with rheumatoid and psoriatic arthritis","volume":"42","author":"Armas-Gonz\u00e1lez","year":"2015","journal-title":"J Rheumatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.autrev.2014.10.010","article-title":"Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases","volume":"14","author":"Mackern-Oberti","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/annrheumdis-2018-214138","article-title":"Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis","volume":"4","author":"Wade","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/jid.2012.390","article-title":"CD8+ T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-\u03b3","volume":"133","author":"Gunderson","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar3817","article-title":"Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features","volume":"14","author":"Celis","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","article-title":"Ustekinumab, an anti-IL-12\/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: Results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-c","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","article-title":"Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial","volume":"395","author":"Mease","year":"2020","journal-title":"Lancet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(20)30265-8","article-title":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF\u03b1 inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial","volume":"395","author":"Deodhar","year":"2020","journal-title":"Lancet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1136\/annrheumdis-2017-eular.1576","article-title":"Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial","volume":"389","author":"Nash","year":"2017","journal-title":"Lancet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/art.40581","article-title":"Brief report: interleukin-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses","volume":"70","author":"van Mens","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumour necrosis factor-alpha (TNF-\u03b1) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1196\/annals.1402.013","article-title":"Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis","volume":"1117","author":"Mori","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20111566","article-title":"TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J","volume":"209","author":"Zhao","year":"2012","journal-title":"J Exp Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the immunopathogenesis of spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","article-title":"Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)","volume":"73","author":"Mease","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/art.22379","article-title":"Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the Adalimumab effectiveness in psoriatic arthritis trial","volume":"56","author":"Gladman","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/art.20335","article-title":"Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression","volume":"50","author":"Mease","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B97","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1600-0625.2010.01089.x","article-title":"Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment","volume":"19","author":"de Groot","year":"2010","journal-title":"Exp Dermatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/ard.2003.018085","article-title":"Early effects of tumour necrosis factor \u03b1 blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis","volume":"63","author":"Goedkoop","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/ard.2008.091389","article-title":"A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue","volume":"68","author":"Van Kuijk","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.4049\/jimmunol.167.7.4075","article-title":"IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis","volume":"167","author":"McInnes","year":"2001","journal-title":"J Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","article-title":"Macrophage-derived cytokine and nuclear factor \u03baB p65 expression in synovial membrane and skin of patients with psoriatic arthritis","volume":"43","author":"Danning","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar3781","article-title":"Functional role of IL-22 in psoriatic arthritis","volume":"14","author":"Mitra","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/eji.201948138","article-title":"Presence, function, and regulation of IL-17F-expressing human CD4+ T cells","volume":"50","author":"Burns","year":"2020","journal-title":"Eur J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/rheumatology\/kez358","article-title":"Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis","volume":"59","author":"Boutet","year":"2020","journal-title":"Rheumatology."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment","volume":"65","author":"Van Kuijk","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.39649","article-title":"Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis","volume":"68","author":"Ciccia","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3899\/jrheum.100068","article-title":"Enthesitis and related changes in the knees in seronegative spondyloarthropathies and skin psoriasis: magnetic resonance imaging case-control study","volume":"37","author":"Emad","year":"2010","journal-title":"J Rheumatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two\u2013week, prospective, open-label feasibility study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/art.41239","article-title":"Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis","author":"Simon","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-019-1957-0","article-title":"Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation - Data from the prospective IVEPSA study","volume":"21","author":"Kampylafka","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01863","article-title":"Molecular characterization of human lymph node stromal cells during the earliest phases of rheumatoid arthritis","volume":"10","author":"Karouzakis","year":"2019","journal-title":"Front Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/eji.201646393","article-title":"Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis","volume":"46","author":"Ramwadhdoebe","year":"2016","journal-title":"Eur J Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1038\/cti.2016.8","article-title":"Human lymph-node CD8+ T cells display an altered phenotype during systemic autoimmunity","volume":"5","author":"Ramwadhdoebe","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/annrheumdis-2012-202990","article-title":"The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis","volume":"72","author":"Van Baarsen","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/rheumatology\/key428","article-title":"Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis","volume":"58","author":"Ramwadhdoebe","year":"2019","journal-title":"Rheumatology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ijcm.2013.412A2001","article-title":"Experience of patients undergoing mini-arthroscopy compared to MRI in the earliest phases of arthritis","volume":"4","author":"de Hair","year":"2013","journal-title":"Int J Clin Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1002\/art.38128","article-title":"Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritis","volume":"65","author":"Van De Sande","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B124","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/ard.2010.139287","article-title":"Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time?","volume":"70","author":"Van De Sande","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"11310","DOI":"10.1371\/journal.pone.0011310","article-title":"The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis","volume":"5","author":"Lindberg","year":"2010","journal-title":"PLoS ONE."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.27.440770","article-title":"Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: a prospective study","author":"Van Baarsen","year":"","journal-title":"bioRxiv Prepr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.38273","article-title":"Features of the synovium of individuals at risk of developing rheumatoid arthritis : Implications for understanding preclinical rheumatoid arthritis","volume":"66","author":"De Hair","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/ard.2010.139527","article-title":"Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase","volume":"70","author":"Van De Sande","year":"2011","journal-title":"Ann Rheum Dis."}],"updated-by":[{"DOI":"10.3389\/fmed.2021.761410","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.711823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T14:18:54Z","timestamp":1631024334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.711823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":128,"alternative-id":["10.3389\/fmed.2021.711823"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.711823","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fmed.2021.761410","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"article-number":"711823"}}